- Latest week
- 17 Jul 2026
- Close
- 14.791000
- Fair value
- 11.311514
- Next-week expectancy
- Undecided 53.05%
BIOT Chart Pack
L&G Pharma Breakthrough UCITS ETF
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, BIOT rose 6.26%, moving from 13.92 to 14.79. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 4.11 and has improved across the 12-week window. Market Dynamics is 1.15 on the latest week. Next-week expectancy is undecided at 53.05% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 14.79
- 12-Week Change
- 6.26%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.05%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 4.11
- Market Dynamics
- 1.15
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 14.79
- 12-Week Change
- 6.26%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.05%
- Signal Weeks
- 9 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 4.11
- Market Dynamics
- 1.15
Over the latest 12 completed weeks ending 2026-07-17, BIOT rose 6.26%, moving from 13.92 to 14.79. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 9 of the last 12 weeks. Relative Strength is 4.11 and has improved across the 12-week window. Market Dynamics is 1.15 on the latest week. Next-week expectancy is undecided at 53.05% based on similar historical setup states.